SEC Form 4 · accession 0001104659-18-040813
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary S Jacob
Officer — Executive Chairman · Director
Period of report
Jun 15, 2018
Accepted (ET)
Jun 18, 2018 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2018 | M | 474,961 | $0.50 | A | 877,640 | D | |
| Common StockF1 | Jun 15, 2018 | F | 131,934 | $0.00 | D | 745,706 | D | |
| Common StockF2 | Jun 15, 2018 | F | 150,246 | $0.00 | D | 595,460 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF3 | $0.50 | Jun 15, 2018 | M | 474,961 | D | — | Jul 3, 2018 | Common Stock | 474,961 | 6,513,342 | D |
Explanation of responses
- F1Represents the number of shares forfeited to the Company in payment of the exercise price of the stock options.
- F2The reporting person is reporting the withholding by Synergy Pharmaceuticals Inc. of 150,246 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the exercise of the stock options on June 15, 2018.
- F3158,320 options vested on 7/3/2009 and 7/3/2010 and 158,321 vested on 7/3/2011